Search: 2018 EU Meeting Faculty
Results 1 - 8 of 8

Rachel Jones

Petunia Health Ltd

Helene Karcher

Vice-President and Global Head, Real-World Modeling
Analytica LA-SER

Bio: Helene has 15 years of experience in quantitative methods applied to impact decisions in health care as an academic, a drug developer and a consultant. She develops and coordinates Analytica Laser's offer in modeling and simulation, and heads a global team of project managers, data scientists and modelers in 5 countries. Helene has hands-on project experience with the whole drug development process from drug discovery, pre-clinical and clinical development to market access and reimbursement. Her modeling skills similarly span a wide range from systems biology and differential equation modeling to longitudinal mixed-effects models and Bayesian statistics. Helene has led the strategy for several submissions, prepared meetings and interacted with a range of regulatory and HTA agencies. Prior to joining Analytica Laser, Helene contributed to the creation and expansion of the Novartis Modeling & Simulation group in the USA and in Switzerland. She received for this work the Pierre Faurre award for significant, innovative contributions to science and its translation in industry. During her 6 years at Novartis, Helene also acted as scientific expert and project manager for the preclinical and clinical development of 14 new compounds in multiple indications. Helene holds a physics & engineering degree from Ecole Polytechnique, France and a PhD in systems biology from MIT, USA.

Robert Kiley

Head of Open Research
Wellcome Trust

Bio: Robert Kiley is Head of Open Research at the Wellcome Trust where he is responsible for developing and implementing an open research strategy. The overarching aim is to help ensure that researchers are equipped, empowered and motivated to make research outputs findable, accessible and usable and to use these outputs to accelerate research and improve health. Over the past decade Robert has played a leading role in the implementation of Wellcome's open access policy and overseeing the development of the Europe PubMed Central repository. Robert also acts as the point of contact for eLife, the open-access research journal, launched in 2012 with the support of the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust, and more recently championed the work to create a new open publishing platform for Wellcome researchers - Wellcome Open Research. Robert is a qualified librarian and an Associate Member of CILIP. Robert also sits as a Director on the ORCID Board.

Elizabeth Knowles

Associate Editorial Director, Medicine & Health
Taylor & Francis Group

Type of Company:
Professional Degrees: BA/BS

Bio: Liz is Associate Editorial Director for the Medicine & Health journals at Taylor & Francis and has worked on medical journals for the last 10 years. She currently works on the rapid publication journals CMRO and Postgraduate Medicine as well as with the in house Expert Collection commissioning team. Her role is to find the most relevant journal for content being submitted to Taylor & Francis by medical communication and pharmaceutical companies, as well as academics.

Tim Koder

Communications Director
Oxford PharmaGenesis Ltd

Type of Company:
Communications Agency

Bio: Tim has a strong interest in practical improvements that we can make to medical and scientific publishing. Through Neuroscience BSc at UCL then MSc, PhD and a brief postdoc on the neuropharmacology of recognition memory at the University of Bristol, it was more the discussion of science than the bench work that satisfied. Tim moved from the lab to publishing, first as a Production Editor on medical books at Taylor & Francis then as a Development Editor on trade publications and websites at Informa Healthcare. To move closer to the science content, Tim joined Caudex in 2007, and trained as a medical writer and account manager. Wider experiences gained at Communigen and Ogilvy HealthWorld have led to a Communications Director role at Oxford PharmaGenesis. Tim's primary job at Oxford PharmaGenesis is to improve clients' medical affairs capabilities, especially in medical evidence, by simplifying connections between local companies and global functions, with strategy, digital systems and human contact. Publications, medical communications, patient engagement, and other work supporting medical affairs increasingly depend on evidence. To create credible evidence means choosing the right means of engagement, data collection and analysis, then communication. Publications remain central to this process, and the quality threshold of the publication process is playing a stronger role than ever in informing evidence planning. At the point of publication though, there are some well-known problems with speed, transparency and accessibility. To play a role in addressing this, Tim leads the Open Pharma project, facilitating the conversation between pharma publications teams, publishers and other stakeholders, to identify together how innovations in publishing can improve the model for disseminating pharma research.

Paul Lane

Associate Director Medical Communications
Biomarin Pharmaceutical Inc

Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (3/2010)

Bio: Paul conducted his Doctoral research into the physiological roles of nitric oxide at Weill Medical College of Cornell University. After serving on the faculty at Weill, Paul worked as a freelance consultant specializing in start-up grants for biotechnology companies, before transitioning full-time to medical publications. He has been a publications professional for over 10 years and has worked on programs spanning all stages of drug development in a variety of therapeutic areas. Until recently, Paul was responsible for Digital and Social Media strategy at Envision Pharma Group, but has now moved on to run publication programs for various rare diseases at Biomarin. The shift from print to web-based publications has been an area of interest since Paul authored a review in one of the first online journals (Science:STKE) in 2001. Much has changed since then, with journals and congresses now offering a plethora of enhancements and the rise of social media as a channel for information dissemination. These additions not only change the way in which medical information is consumed, but also the methods we use to assess the impact of a publication.

Rebecca Lawrence

Managing Director

Bio: Rebecca Lawrence is Managing Director of F1000, providers of a series of tools and services to support the research community in writing, publishing, discovering and evaluating new scientific findings. She was responsible for the launch of the novel open science publishing platform F1000Research. She has subsequently led the initiative behind the recent launch of Wellcome Open Research, Gates Open Research, and many other funder- and institution-based publishing platforms that aim to start a new trajectory in the way scientific findings and data are communicated and ultimately research and researchers are evaluated. She is a member of the High-Level Advisory Group for the EU's Open Science Policy Platform, and has been co-Chair of a number working groups focussing on data and peer review, for organisations including the Research Data Alliance (RDA), CASRAI and ORCID. She has worked in STM publishing for 15 years, originally trained and qualified as a pharmacist, and holds a PhD in Cardiovascular Pharmacology.

Alison Lovibond

Director, Scientific & Editorial Services
Articulate Science

Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (3/2017)

Bio: Alison Lovibond is currently Director, Scientific and Editorial Services for Articulate Science, part of Nucleus Global. She has over 12 years of experience of strategic publications planning and delivery, gained within medical communications agencies. Alison holds a PhD in cellular biology from the University of London and has been CMPP certified since 2011.